A&M's National Tax Office provides clients with access to domestic and global tax experts to advise you on complex tax issues and deliver insights on evolving regulations and tax developments.
A Knowledgeable and Experienced Team.
Directed by Practice Leader and Managing Director Kevin M. Jacobs, our global team of seasoned professionals who are trained across all tax disciplines advise you on your current and future needs. A&M's National Office relies on the deep technical expertise our professionals bring to help our clients and professionals.
A&M National Tax Office also helps foresee potential future implications by closely monitoring the ever-changing tax law, regulations and emerging trends to alert clients and A&M professionals on changes in the industry to help navigate them seamlessly.
We work tirelessly to work with our clients to achieve their goals, anticipating both possible complications and opportunities to create value.
Connect with us or your A&M contact to learn more about how we can support you.
Code of Practice 9 – What Is It and Is It Right for You?
December 12, 2025
At A&M, we regularly work alongside our clients’ existing advisors to ensure that they benefit from our extensive experience in managing Code of Practice 9 enquiries.
A&M Benefits Reference Guide
December 11, 2025
Many of the limits that pertain to qualified retirement plans and benefit plans are set by the Internal Revenue Service (IRS) and are subject to cost-of-living adjustments. In 2026, employees will be able to increase their retirement savings and contributions to health savings accounts as a result of the increased limits. The IRS limits for 2026 are summarized in the table below along with certain important compliance deadlines.
Pharma in Focus: A Prescription for Thai Tax & Tariff Health
December 8, 2025
Alvarez & Marsal recently hosted an engaging and practical session tailored for tax, finance, and trade professionals in the pharmaceutical industry. This first edition of our Thailand Tax Talk: Industry Series explored how tax leaders in the pharma sector can respond to increasing regulatory pressure, operational complexity, and cross-border trade disruption.
Supreme Court Upholds Delhi High Court Ruling: Indian Subsidiary Does Not Automatically Constitute PE, and No Further Profit Attribution Is Warranted Once the Subsidiary Arm’s Length Remuneration Is Paid
December 5, 2025
The Supreme Court’s affirmation of the Delhi High Court ruling in the Progress Rail case provides important clarity on Permanent Establishment standards in India.
The decision reinforces key principles on control, core functions, agency thresholds, and profit attribution.
It further underscores that arm’s-length remuneration to Indian subsidiaries precludes additional attribution.
A significant development for multinational enterprises evaluating their India-linked operating models.
